What are the AACE recommendations for drug selection in the treatment of osteoporosis?

Updated: Sep 26, 2019
  • Author: Monique Bethel, MD; Chief Editor: Herbert S Diamond, MD  more...
  • Print
Answer

Guidelines from the American Association of Clinical Endocrinologists include the following recommendations for choosing drugs to treat osteoporosis [11] :

  • First-line agents: Alendronate, risedronate, zoledronic acid, denosumab

  • Second-line agent: Ibandronate

  • Second- or third-line agent: Raloxifene

  • Last-line agent: Calcitonin

  • Treatment for patients with very high fracture risk or in whom bisphosphonate therapy has failed: teriparatide


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!